P1192: ANTI-PD-1 ANTIBODY (TISLELIZUMAB) COMBINED WITH R-CHOP FOR THE TREATMENT OF PREVIOUSLY UNTREATED PRIMARY MEDIASTINAL B-CELL LYMPHOMA: A PROSPENTIVE PHASE II STUDY
Wu Mei,
Zhu Lin,
LI Shan,
Tu Erde Jia Erbao,
Wang Shanshan,
Liang Xiao,
Hu Xin,
Guo LI,
A Dili Abulikemujiang,
Maimaitirexiati Xianmusiya,
Ren Ruirui,
Wen Shujuan
Affiliations
Wu Mei
1 The Affiliated Oncology Hospital of Xinjiang Medical University, Department of Lymphoma, Urumchi, China
Zhu Lin
1 The Affiliated Oncology Hospital of Xinjiang Medical University, Department of Lymphoma, Urumchi, China
LI Shan
1 The Affiliated Oncology Hospital of Xinjiang Medical University, Department of Lymphoma, Urumchi, China
Tu Erde Jia Erbao
1 The Affiliated Oncology Hospital of Xinjiang Medical University, Department of Lymphoma, Urumchi, China
Wang Shanshan
1 The Affiliated Oncology Hospital of Xinjiang Medical University, Department of Lymphoma, Urumchi, China
Liang Xiao
1 The Affiliated Oncology Hospital of Xinjiang Medical University, Department of Lymphoma, Urumchi, China
Hu Xin
1 The Affiliated Oncology Hospital of Xinjiang Medical University, Department of Lymphoma, Urumchi, China
Guo LI
1 The Affiliated Oncology Hospital of Xinjiang Medical University, Department of Lymphoma, Urumchi, China
A Dili Abulikemujiang
1 The Affiliated Oncology Hospital of Xinjiang Medical University, Department of Lymphoma, Urumchi, China
Maimaitirexiati Xianmusiya
1 The Affiliated Oncology Hospital of Xinjiang Medical University, Department of Lymphoma, Urumchi, China
Ren Ruirui
1 The Affiliated Oncology Hospital of Xinjiang Medical University, Department of Lymphoma, Urumchi, China
Wen Shujuan
1 The Affiliated Oncology Hospital of Xinjiang Medical University, Department of Lymphoma, Urumchi, China
